يعرض 1 - 10 نتائج من 81 نتيجة بحث عن '"Reintervención"', وقت الاستعلام: 1.13s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Schmidt A, Tornetta III P. Treatment of closed tibial fractures. Instr Course Lect. 2003; 52: 607-22.; Zelle B, et al. Treatment of distal tibial fractures without articular involvement: A systematic review of 1125 fractures. J Orthop Trauma. 2006; 20: 76-79.; Im GI, Tae SK. Distal metaphyseal fractures of tibia: a prospective randomized trial of closed reduction and intramedullary nail versus open reduction and plate and screws fixation. J Trauma 2005; 59:1219-23.; Helfet DL, Suk M. Minimally invasive percutaneous plate osteosynthesis of fractures of the distal tibia. Instr Course Lect. 2004; 53:471-5.; Borg T, Larsson S. Percutaneous plating of distal tibial fractures. Preliminary results in 21 patients. Injury. 2004; 35: 608-14.; Borrelli J. Prickett W. Extraosseous blood supply of the tibia and the effects of different plating techniques: A human cadaveric study. J Orthop Trauma 2002; 16(10): 691-95.; Baumgaertel F, Buhl M, Rahn BA. Fracture healing in biological plate osteosynthesis. Injury.1998; 29:3–6.; Janssen KW, Biert J, van Kampen A. Treatment of distal tibial fractures: plate versus nail. A retrospective outcome analysis of matched pairs of patients. Int Orthop. 2007 Oct; 31(5):709-14.; Vallier HA, Le TT, Bedi A. Radiographic and clinical comparisons of distal tibia shaft fractures (4 to 11 cm proximal to the plafond): plating versus intramedullary nailing. J Orthop Trauma. 2008; 22(5): 307-11.; Nork SE, Schwartz A, Agel J. Intramedullary nailing of distal metaphyseal tibial fractures. J Bone Joint Surg Am. 2005; 87(6): 1213-21; Egol K, Weisz R. Does fibular plating improve alignment after intramedullary nailing of distal metaphyseal tibia fractures?. J Orthop Trauma 2006; 20(2): 94-103.; Collinge C, Kuper M, Larson K, Protzman R. Minimally invasive plating of high-energy metaphyseal distal tibia fractures. J Orthop Trauma. 2007; 21: 355–61.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/540/580Test; Núm. 2 , Año 2009 : Abril - Junio; 119; 113; 18; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2434Test; https://doi.org/10.31260/RepertMedCir.v18.n2.2009.540Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    رسالة جامعية
  9. 9
    دورية أكاديمية

    المساهمون: Saavedra Trujillo, Carlos Humberto, Fernanda Cárdenas, Luisa, Sánchez, Laura Catalina, Álzate, Juan Pablo, Diez Salazar, Yulissa Inés, Arévalo Pereira, Kennedy, Velásquez, Juan Pablo, Lasso, Andrés David, Grupo de Investigacion en enfermedades Infecciosas

    وصف الملف: application/pdf

    العلاقة: Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017;10:29; Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, et al. The Surgical Infection Society Revised Guidelines on the Management of IntraAbdominal Infection. Surg Infect. 2017;18:1-76.; Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133-64; Chanana L, Jegaraj MA, Kalyaniwala K, Yadav B, Abilash K. Clinical profile of nontraumatic acute abdominal pain presenting to an adult emergency department. J Family Med Prim Care. 2015;4:422–425.; Brewer BJ, Golden GT, Hitch DC, Rudolf LE, Wangensteen SL. Abdominal pain. An analysis of 1,000 consecutive cases in a University Hospital emergency room. Am J Surg 1976;131:219-223.; Sartelli M, Abu-Zidan FM, Catena F, Griffiths EA, Di Saverio S, Coimbra R, et al. Global validation of the WSES Sepsis Severity Score for patients with complicated intraabdominal infections: a prospective multicenter study (WISS Study). World J Emerg Surg. 2015;10:61.; De Pascale G, Carelli S, Vallecoccia MS, Cutuli SL, Taccheri T, Montini L. Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients. J Crit Care. 2019;50:169-176.; Dalfino L, Bruno F, Colizza S, Concia E, Novelli A, Rebecchi F, et al. Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study. World J Emerg Surg. 2014;20:9-39.; Chong YP, Bae IG, Lee SR, Chung JW, Jun JB5, Choo EJ, et al. Clinical and economic consequences of failure of initial antibiotic therapy for patients with communityonset complicated intra-abdominal infections. PLoS One. 2015:24;10:e0119956.; Edelsberg J, Berger A, Schell S, Mallick R, Kuznik A, Oster G. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect. 2008;9:335-47.; Cirocchi R, Di Saverio S, Weber DG, Taboła R, Abraha I, Randolph J. Laparoscopic lavage versus surgical resection for acute diverticulitis with generalized peritonitis: a systematic review and meta-analysis. Tech Coloproctol. 2017;21:93-110; Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23:682-7.; Sturkenboom MC, Goettsch WG, Picelli G, in 't Veld B, Yin DD, de Jong RB, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60:438-43; Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;18:CD004539.; Leone S, Damiani G, Pezone I, Kelly ME, Cascella M, Alfieri A, et al. New antimicrobial options for the management of complicated intra-abdominal infections.Eur J Clin Microbiol Infect Dis. 2019;38:819-827; Lee YR, McMahan D, McCall C, Perry GK. Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players. Drugs. 2015;75:2097-117.; Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended Spectrum Betalactamases: Definition, Classification and Epidemiology. Curr Issues Mol Biol. 2015;17:11-21; Salles MJ, Zurita J, Mejía C, Villegas MV. Resistant gram-negative infections in the outpatient setting in Latin America. Epidemiol Infect. 2013;141:2459-72; Vallejo M, Cuesta D P, Flórez L E, Correa A, Llanos C E, B Isaza, et al. Características clínicas y microbiológicas de la infección intra-abdominal complicada en Colombia: un estudio multicéntrico. Revista chilena de infectologia.2016;33:261-267.; Cardona Botero, Diego Alexander. Perfil microbiológico y patrones de resistencia antibiótica en peritonitis 2ria y 3ria del Hospital Universitario de la Samaritana. Repositorio institucional UN. [Internet] Año 2018. [Consultado 12 de Noviembre de 2019] Disponible en http://www.bdigital.unal.edu.co/61455/49Test; Jiménez A, Sánchez A, Rey A, Fajardo A. Recuperación de bacterias aerobias y anaerobias de pacientes con apendicitis aguda empleando botellas de hemocultivo. Biomédica. 2019;39:699-06.; Aura Lucia Leal Castro. Boletín informativo Numero 1-10. Grupo para el control de la Resistencia bacteriana de Bogotá.[Internet] 2017. [Consultado:12 Noviembre 2019]. Disponible en: https://www.grupogrebo.org/#BoletinesTest; Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother. 2009;21:3-4; Lutz P, Nischalke Hd, Strassburg Cp, Spengler U. Spontaneous Bacterial Peritonitis: The Clinical Challenge Of A Leaky Gut And A Cirrhotic Liver. World J Hepatol. 2015;27:304-14.; Dever Jb, Sheikh My. Review Article: Spontaneous Bacterial Peritonitis--Bacteriology, Diagnosis, Treatment, Risk Factors And Prevention. Aliment Pharmacol Ther. 2015;41:1116-31.; Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol. 1990;132:910-25; Ceresoli M, Zucchi A, Pisano M, Allegri A, Bertoli P, Coccolini F. Epidemiology of acute cholecystitis and its treatment in Bergamo District, Northern Italy. Minerva Chir. 2016;71:106-13; Halpin V. Acute cholecystitis. BMJ Clin Evid. 2014;20:104-11; Lee TH, Setty PT, Parthasarathy G, Bailey KR, Wood-Wentz CM, Fletcher JG, et al. Aging, Obesity, and the Incidence of Diverticulitis: A Population-Based Study. Mayo Clin Proc. 2018;93:1256-1265; Perez KS, Allen SR. Complicated appendicitis and considerations for interval appendectomy.JAAPA. 2018;31:35-41; Atema JJ, van Rossem CC, Leeuwenburgh MM, Stoker J, Boermeester MA. Scoring system to distinguish uncomplicated from complicated acute appendicitis. Br J Surg. 2015;102:979-90; Reiss R, Nudelman I, Gutman C, Deutsch AA. Changing trends in surgery for acute cholecystitis. World J Surg. 1990;14:567-69; Loozen CS, van Santvoort HC, van Duijvendijk P, Besselink MG, Gouma DJ, Nieuwenhuijzen GA. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ. 2018;363:k3965; Strate LL, Morris AM. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156:1282-1298; Dietch ZC, Duane TM, Cook CH, O'Neill PJ, Askari R, Napolitano LM. Obesity Is Not Associated with Antimicrobial Treatment Failure for Intra-Abdominal Infection. Surg Infect (Larchmt).2016;17:412-21.; Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med. 2019;45:1703-1717; Baré M, Castells X, Garcia A, Riu M, Comas M, Egea MJ. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Health Care. 2006;22:242-8.; Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with communityacquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23:682-7.; Edelsberg J, Berger A, Schell S, Mallick R, Kuznik A, Oster G. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt). 2008;9:335-47; Mikamo H, Monden K, Miyasaka Y, Horiuchi T, Fujimoto G, Fukuhara T, et al. The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections. J Infect Chemother. 2019;25:111-116.; Sturkenboom MC, Goettsch WG, Picelli G, in 't Veld B, Yin DD, de Jong RB, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60:438-43.; Tellado JM, Sen SS, Caloto MT, Kumar RN, Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis. 2007;39:947-55; Van de Groep K, Verhoeff TL, Verboom DM, Bos LD, Schultz MJ, Bonten MJM, et al. Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care. 2019;52:258-264.; O. van Ruler, J. J. S. Kiewiet, R. J. van Ketel, M. A. Boermeester. Initial microbial spectrum in severe secondary peritonitis and relevance for treatment. Eur J Clin Microbiol Infect Dis. 2012;31:671–682; Qin X, Tran BG, Kim MJ, Wang L, Nguyen DA, Chen Q, et al. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia. International journal of antimicrobial agents. 49;579–588.; Solomkin J, Evans D, Slepavicius A, Lee P, Marsh A, Tsai L, et al. Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections treated With Eravacycline (IGNITE1)Trial. A Randomised Clinical Trial. JAMA Surg. 2017;152:224–232.; Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. Int J Antimicrob Agents. 2009;34:439–445.; Catena F, Vallicelli C, Ansaloni L, Sartelli M, Di Saverio S, Schiavina R, et al. T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam. BMC Gastroenterol. 2013;13:76-82.; Hiroshige Mikamo, Kauteru Monden, Yoshiaki Miyasaka, Tetsuya Horiuchi, Go Fujimoto, Takahiro Fukuhara, et al. The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicates intra-abdominal infections. J Infect Chemother. 25;111-116.; Chen Z, Wu J, Zhang Y, Wei J, Leng X, Bi J,et al. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis. 2010;10:217-22.; Towfigh S, Pasternak J, Poirier A, Leister H, Babinchak T. A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intraabdominal infections. Clin Microbiol Infect. 2010;16:1274–1281.; Chen CW, Ming CC, Ma CJ, Shan YS, Yeh YS, Wang JY. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections. Surg Infect (Larchmt). 2013;14:389–396; Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, et al. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis. 2016;16:661–673.; Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, et al. Efficacy and Safety of CeftazidimeAvibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intraabdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program. Clin Infect Dis. 2016;62:1380–1389; Solomkin J, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, et al. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECTcIAI). Clin Infect Dis. 2015;60:1462–1471.; Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, et al. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections. Ann Surg. 1993;217:115–121.; Smith JA, Skidmore AG, Forward AD, Clarke AM, Sutherland E. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Ann Surg. 1980;192:213– 220.; Infections Study Group of Intraabdominal, A Randomized Controlled Trial of Ampicillin plus Sulbactam vs. Gentamicin plus Clindamycin in the Treatment of Intraabdominal Infections: A Preliminary Report. Reviews of Infectious Diseases;8:S583–S588.; Karran SJ. Ravichandran D. Karran SE. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intraabdominal Infection Study Group. Eur J Surg Suppl. 1994 ;573 :61–66.; Shyr YM, Lui WY, Su CH, Wang LS, Liu CY. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections. Zhonghua Yi Xue Za Zhi (Taipei). 1995;56:102–108.; Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farèse M, Seguin P, et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med. 2018;44:300–310.; Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection [published correction appears in N Engl J Med. 2015;372:1996–2005.; Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Claridge JA, et al. Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy. J Am Coll Surg. 2016;222:440–446.; Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Coimbra R, et al. Percutaneously drained intra-abdominal infections do not require longer duration of antimicrobial therapy. J Trauma Acute Care Surg. 2016;81:108–113.; Rattan R, Allen CJ, Sawyer RG, Mazuski J, Duane TM, Askari R, et al. Patients with Risk Factors for Complications Do Not Require Longer Antimicrobial Therapy for Complicated Intra-Abdominal Infection. Am Surg. 2016;82:860–866.; Shein M, Marshall J. Source Control: A Guide to the Management of Surgical Infections. Berlin: Springer-Verlag;2003.; Pieracci FM, Barie PS. Management of severe sepsis of abdominal origin. Scand J Surg. 2007;96:184-196.; Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, et al. Protocol 017 Study Group. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg. 2003;237:235-245.; Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195-283.; De Waele J, Lipman J, Sakr Y, Marshal J C, Vanhems P, Barrera Groba C, et al. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of Outcome. BMC Infect Dis. 2014;14:420.; Membrilla-Fernández E, Sancho-Insenser JJ, Girvent-Montllor M, Álvarez-Lerma F, Sitges-Serra A. Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis. Surg Infect (Larchmt). 2014;15:806-814.; Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214:543-549.; Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B; DRAGON Study Team. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. Int J Antimicrob Agents. 2009;34:439-45.; Genné D, Menetrey A, Jaquet A, Indino P, Sénéchaud C, Siegrist HH. Treatment of secondary peritonitis: is a less expensive broad-spectrum antibiotic as effective as a carbapenem? Dig Surg. 2003;20:415-20.; Maltezou HC, Nikolaidis P, Lebesii E, Dimitriou L, Androulakakis E, Kafetzis DA. Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2001;20:643-6.; Paterson DL, Robson JMB, Wagener MM. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Internal Med. 1998;13:735-739; Muñetón López, G. A. (2021). Efectividad de los diferentes esquemas de tratamiento antibiótico usados en el tratamiento de la infección intraabdominal en hospitales de segundo y tercer nivel de Bogotá [Tesis de especialidad, Universidad Nacional de Colombia]. Repositorio Institucional; https://repositorio.unal.edu.co/handle/unal/79018Test

  10. 10
    دورية أكاديمية